Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503086 · ClinicalTrials.gov registry record · NA
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
A NA study of Brain Neoplasm and Recurrent Brain Neoplasm, sponsored by Children's Oncology Group.
- Active
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 20
- Study locations
NCT01503086 is a NA study of Brain Neoplasm and Recurrent Brain Neoplasm that is active but no longer recruiting, run by Children's Oncology Group. The registered enrollment target is 45 participants, roughly in line with the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target. The trial reports 20 study locations across 14 states.
The verdict
NCT01503086, a NA study of Brain Neoplasm and Recurrent Brain Neoplasm, is active but no longer recruiting, sponsored by Children's Oncology Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 20
- Study locations
Study Summary
This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improve the well-being and quality of life of patients with cognitive (physical and mental) function difficulties caused by radiation therapy to the brain.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- PROCEDURE Cognitive Assessment
- OTHER Computer-Assisted Cognitive Training
- PROCEDURE Psychosocial Assessment and Care
Study Locations (20)
Florida
- Broward Health Medical Center - Fort Lauderdale
- Golisano Children's Hospital of Southwest Florida - Fort Myers
- Nemours Children's Clinic-Jacksonville - Jacksonville
- Nemours Children's Hospital - Orlando
- Tampa General Hospital - Tampa
Missouri
- Children's Mercy Hospitals and Clinics - Kansas City
- Washington University School of Medicine - St Louis
North Carolina
- Duke University Medical Center - Durham
- Wake Forest University Health Sciences - Winston-Salem
Colorado
- Children's Hospital Colorado - Aurora
Delaware
- Alfred I duPont Hospital for Children - Wilmington
District of Columbia
- Children's National Medical Center - Washington D.C.
Georgia
- Children's Healthcare of Atlanta - Arthur M Blank Hospital - Atlanta
Idaho
- Saint Luke's Cancer Institute - Boise - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2014-07-30 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01503086
The ClinicalTrials.gov registry entry for NCT01503086 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 49-participant average among 9 other Brain Neoplasm trials with a reported enrollment target. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Brain Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01503086 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Florida, Missouri, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01503086 about?
NCT01503086 is a clinical study titled "Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy". This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improv...
What is the current status of trial NCT01503086?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2014-07-30. Estimated completion is 2026-03-31.
What conditions does trial NCT01503086 study?
This clinical trial studies the following conditions: Brain Neoplasm, Recurrent Brain Neoplasm.
What interventions are being tested in trial NCT01503086?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Cognitive Assessment (PROCEDURE), Computer-Assisted Cognitive Training (OTHER), Psychosocial Assessment and Care (PROCEDURE).
Who is sponsoring clinical trial NCT01503086?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01503086 being conducted?
This trial has 20 study locations across Colorado, Delaware, District of Columbia, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
RECRUITING · NA
-
Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors
ACTIVE NOT RECRUITING · NA
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
Tumor Related Epilepsy
RECRUITING
-
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
RECRUITING · Phase 2
-
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.